Johnson & Johnson's TECNIS Odyssey has shown promising early real-world data, potentially challenging Alcon's position. Additionally, RXST's light adjustable lens (LAL) continues to gain momentum ...
Johnson & Johnson (NYSE: JNJ) expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses ...
A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual ...
In a report released today, Julien Ouaddour from Bank of America Securities maintained a Hold rating on Koninklijke Philips (PHG – ...
DKSH Healthcare Business Unit, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, is excited to announce a series of initiatives across Asia in observance of ...
Class 2 listed for wet locations, cULus, IP68, RoHS, IC Rated, Made in USA, approved for closet/storage space installation per NEC 410.16(A)(3) and 410.16(C)(5) ...
Hosted on MSN19d
Land Rover revives V8 Defender ... at a costThen, Land Rover swaps in a 300kW/515Nm 5.0-litre petrol V8 and eight-speed automatic gearbox along with Bilstein dampers, Eibach springs and uprated four-piston Alcon brakes ... or a full ...
Intraocular lens choice, as facilitated by the surgeon, can connect the patient with the appropriate device for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback